Patterns of adrs and risk factors involved: Study in cardiology unit of an indian tertiary care center

Internet Journal of Pharmacology

Volumn 8, Issue 1, 2010, Pages

  Kaur, Sharminder ^a   Kapoor, Vinod ^b   Mahajan, Rajiv ^b   Lal, Mohan ^a   Gupta, Seema ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

^b Adesh University   (India)

Author keywords

Adverse drug reaction monitoring; Cardiology; Incidence; Risk factors

Indexed keywords

ANTIINFECTIVE AGENT; CARDIOVASCULAR AGENT; CONTRAST MEDIUM; DIURETIC AGENT; NITRATE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; INDIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SKIN ALLERGY; TERTIARY HEALTH CARE;

EID: 77954299086     PISSN: None     EISSN: 15312976     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998; 316: 1295-98.
2. Bonow RO, Smaha LA, Smith SC Jr, Mensah GA, Lenfant C. The international burden of cardiovascular diseases: Responding to the emerging global epidemic. Circulation 2002; 106: 1602.
3. LaPointe NM, Jollis JG. Medication errors in hospitalized cardiovascular patients. Arch Intern Med 2003; 163: 1461-66.
4. Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital: A nine year experience. Arch Intern Med 1997; 157: 1569-76.
5. Prakash S. Pharmacovigilance in India. Indian J Pharmacol 2007; 39: 123.
6. Biswas P, Biswas AK. Setting standards for proactive pharmacovigilance in India: The way forward. Indian J Pharmacol 2007; 39: 124-8.
7. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res 2006; 54: 226-33.
8. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in Internal Medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62: 143-49.
9. Suspected adverse drug reaction reporting form. Central drugs standard control organization. Available from: http://cdsco.nic.in/html/ADR_form_PDF_file.pdf
10. Edwards IR, Aronson JK. Adverse drug reactions: definition, diagnosis and management. Lancet 2000; 356: 1255-59.
11. Medical Council of India: Minimum Requirements for 150 MBBS Admissions Annually Regulations (Amendment) 2009, No. MCI. 34(41)/2009-Med./20072 (July 08, 2009). p. 76. Available from: http://mciindia.org/helpdesk/how_to_start/STANDARD%20FOR%20150.pdf [cited 2009 Aug 27]
12. Koleva T, Madzharova Iu, Baleva V, Dragoǐcheva Ts, Stoǐkova K. Side effects of cardiovascular drugs [abstract]. Vutr Boles 1989; 28: 24-30.
13. Davies DM. History and epidemiology. In: Davies DM, ed. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1977. p. 1-7.
14. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-11.
15. Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, et al. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 1999; 159: 2553-60.
16. Hughes SG. Prescribing for the elderly patients: Why do we need to exercise caution? Br J Clin Pharmacol 1998; 46: 531-33.